Tag: Aurinia Pharmaceuticals

October 9, 2016

5 Top NASDAQ Biotech Stocks: Aurinia Pharmaceuticals Up 90 Percent Year-To-Date

Last week's top gainer was Aurinia Pharmaceuticals, followed by Neptune Tech & Bioresources, Madrigal Pharmaceuticals, Biodel and Curis
October 2, 2016

5 Top NASDAQ Biotech Stocks: Array BioPharma Shares Up On Clinical Trial Results

Last week's top gainer was Array BioPharma, followed by Allied Healthcare Products, Ekso Bionics Holdings, Aurinia Pharmaceuticals and GW Pharmaceuticals.
September 30, 2016

Aurinia Announces That Voclosporin Achieves Primary Endpoints

Aurinia Pharmaceuticals today announced that in addition to voclosporin (23.7 mg BID) achieving its primary endpoint of Complete Remission (CR)...